Creotech Instruments

Creotech Instruments OpEx/Revenue

The Operating Expenses to Revenue Ratio of Creotech Instruments (CRI.WA) as of Nov 12, 2026 is 6.32 %. In the previous year, Operating Expenses to Revenue Ratio was 68.02 % — a change of -90.70% (lower).

OpEx/Revenue

6.32 %

YoY

-90.70%

Last updated:

Operating Expenses to Revenue Ratio of Creotech Instruments is 2025 6.32 % . Operating Expenses to Revenue Ratio of Creotech Instruments was 2024 68.02 % . It decreases by -90.70% lower compared to the previous year.

The Creotech Instruments OpEx/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

OpEx/Revenue
Date
OpEx/Revenue
Jan 1, 2019
66.90 PLN
Jan 1, 2020
62.45 PLN
Jan 1, 2021
88.02 PLN
Jan 1, 2022
81.08 PLN
Jan 1, 2023
68.02 PLN
Jan 1, 2025
6.32 PLN
The Creotech Instruments OpEx/Revenue history
YEAROpEx/RevenueYoY
6.32 %-90.70%
68.02 %-16.11%
81.08 %-7.88%
88.02 %+40.94%
62.45 %-6.64%
66.90 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Creotech Instruments Stock analysis

What does Creotech Instruments do? Creotech Instruments SA generates revenue through the sale of satellite systems and components, particularly Earth Observation imaging systems and UAV technology for altitude obstacle monitoring. The company specializes in developing electronic products and IT systems for space technologies, targeting clients in defense, aerospace, and scientific research sectors. Its products include specialized electronics for quantum computing, cryptography, and high-energy physics applications, alongside microsatellite development services. The firm serves government agencies, research institutions, and private aerospace firms requiring advanced space-based solutions. Creotech Instruments SA's primary revenue streams come from contracts with entities needing Earth Observation data and UAV-based monitoring systems. The company's expertise in quantum-related electronics and microsatellite hardware enables it to secure projects in quantum physics laboratories and high-energy physics research. Its product portfolio focuses on niche markets where precision and advanced technology are critical, such as quantum computing infrastructure and satellite-based environmental monitoring. The business model relies on long-term contracts with specialized clients in defense, aerospace, and scientific research. Creotech Instruments SA develops custom solutions for quantum physics applications, including hardware for quantum computers and cryptography systems, which are sold to laboratories and research centers. Its microsatellite development services are tailored to clients requiring compact, high-performance space systems for Earth observation and scientific experiments. Creotech Instruments is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Creotech Instruments stock

Operating Expenses to Revenue Ratio of Creotech Instruments is 6.32 % in 2025.

Operating Expenses to Revenue Ratio of Creotech Instruments changed from 68.02 % to 6.32 %, representing a -90.70% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Expenses to Revenue Ratio Creotech Instruments since 2006 – with annual values, charts, and detailed analysis.

The OpEx/Revenue ratio measures total operating expenses as a percentage of revenue. Declining ratios suggest improving operational leverage.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Operating Expenses to Revenue Ratio's Creotech Instruments with sector peers and the industry average to assess whether it is attractive.

To evaluate Operating Expenses to Revenue Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Operating Expenses to Revenue Ratio.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Creotech Instruments

All Key Metrics — Creotech Instruments